secwatch.observer — SEC 8-K summary
======================================

Issuer:     PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)
CIK:        0001552189
Form:       8-K
Filed at:   2021-12-20T23:59:59+00:00
Accession:  0001493152-21-031991
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Panacea Life Sciences restates Q3 2021 financials; board cites errors in revenue, COGS, leases, warrants
--------------------------------------------------------------------------------

- Board concluded Q3 2021 unaudited financials filed Nov 22 should no longer be relied upon due to errors in revenue, cost of goods sold, lease liability, options and warrants.
- Restated financials filed in amended 10-Q/A on Dec 17, 2021, affecting balance sheet, income statement, equity, and cash flow statements.
- Original 10-Q was not reviewed by independent accountant RBSM prior to filing; amended report was reviewed and may be relied upon.
- Board and CEO discussed the non-reliance determination with representatives of RBSM.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1552189/000149315221031991/0001493152-21-031991-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1552189/000149315221031991/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-031991

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer